Mary Martin
Obstetrics & Gynecology · Beaumont, TXNPI 1245244359
Payments from drug & device makers
What this record shows
Axonics, Inc. accounts for 73.7% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2022 at $883 and has fallen 84.5% since, to $137 in 2025.
Across 29 payments — averaging $44.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axonics, Inc.$960
- Revance Therapeutics, Inc.$137
- Astellas Pharma US Inc$113
- AbbVie$34
- Agile Therapeutics, Inc.$22
- Scynexis, Inc.$19
- plus $16 from 1 others
Across 215 payments — averaging $13,249 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Modernatx, Inc.$2.2M
- Sanofi$625K
- Teva Pharmaceuticals USA, Inc.$30K
- Endo Pharmaceuticals Inc.$18K
- Braintree Laboratories, Inc.$2K
What the payments were for
- Travel & lodging$56343%
- Food & beverage$73957%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axonics, Inc. | 16 | $960 |
| Revance Therapeutics, Inc. | 1 | $137 |
| Astellas Pharma US Inc | 7 | $113 |
| AbbVie | 2 | $34 |
| Agile Therapeutics, Inc. | 1 | $22 |
| Scynexis, Inc. | 1 | $19 |
| Aspira Women's Health Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,302 in reported general payments places this provider in the 55th percentile of 3,099 obstetrics & gynecology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 11 | $10,027 |
| Estradiol | 16 | $2,809 |
| Metformin Hcl ErMetformin Hcl | 18 | $304 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Beaumont
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Dale StovallDallas$590K
- Karyn-Anne CumberbatchMissouri City$452K
- Robert AsgharianEl Paso$366K
- Catherine HansenWebster$357K
- Lisa JukesBee Cave$270K
- Susan CrockettLive Oak$269K
- Henry Garza IiiSan Antonio$258K
- Rene LunaMcAllen$257K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.